Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,472.3
21.5 (0.88%)

 

  • STI Straits Times Index
    2,472.3
    21.5 (0.88%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,509.1
    8.3 (0.56%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,235.4
    -75.7 (-0.32%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,219.4
    -3.8 (-0.12%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,204.6
    116.8 (0.51%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,945.8
    103.0 (2.13%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,059.2M
  • Value: 869.4M
  • Rise: 172
  • Fall: 134
  • Unch: 475

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.051+0.005
Sembcorp Marine0.142-0.002
Alset0.062-0.001
Samko Timber0.034+0.001
Avarga0.260+0.015
AnAn Intl0.033+0.004
Addvalue Tech0.024+0.001
Rex Intl0.146+0.003
Singtel2.140+0.020
ThaiBev0.585-

World Indices

World Indices
Name Last Change
Nasdaq 10,672.3 +39.3
HSI 23,235.4 -75.7
HSCEI 9,302.6 -68.6
Jakarta 4,945.8 +103.0
Nikkei 225 23,204.6 +116.8
SSE Comp 3,219.4 -3.8
Shanghai A 3,374.1 -4.0
Shanghai B 247.4 +0.8
KOSPI 2,278.8 +6.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

KALVISTA PHARMACEUTICALS INC KALVISTA PHARMACEUTICALS
Updated on 25 Sep 2020 (End of trading day)
Last (USD): 12.890 Change: +0.140 High: 12.940 Remarks: -
Change (%): +1.10 Low: 12.570
Open 12.740 Yesterday's Close 12.75
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 31,582 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.62590 Trailing EPS (USD) e -1.82007 NAV (USD) b 4.1566
PE a - Trailing PE f - Price / NAV b 3.1011
Dividend (USD) d - Cash In Hand (USD) g 1.0059 Issued & Paid-up Shares c 17,907,600
Dividend Yield (%) d - Price / Cash In Hand g 12.814 Treasury Shares h -
Market Cap (M) 230.829 Enterprise Value (M) 168.021
Piotroski F Score 1 Exchange Code KALV Par Value ( $ ) n.a.
52 Weeks Volatility (%) 89.17 Free Float (%) 65.2
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 14 Sep 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 22 Nov 2016.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference KALVISTA PHARMACEUTICALS INC NASDAQ 230.829 - - 3.1011 -
Industry Pharmaceuticals: Major NASDAQ 2,600.863 114.250 71.024 4.0822 0.005
Local Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NASDAQ 145,690.436 - - - 2.468
Local Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 127,857.439 39.296 10.409 1.7983 2.302
Local Peer ROYALTY PHARMA PLC NASDAQ 24,326.737 10.358 10.358 5.8518 -
Local Peer CUREVAC NV NASDAQ 7,839.490 - - -163.6330 -
Local Peer REPLIGEN CORP NASDAQ 7,576.125 353.841 244.873 6.8872 -
Local Peer HUTCHISON CHINA MEDITECH SPON ADS EACH REPR 5 ORD SHS NASDAQ 4,675.715 - - 13.6668 -
Local Peer GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 NASDAQ 4,331.812 6.191 7.037 0.7189 2.680
Local Peer LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS NASDAQ 4,104.067 - - 10.2347 -
Local Peer ALLAKOS INC NASDAQ 3,926.792 - - 8.7847 -
Local Peer TURNING POINT THERAPEUTICS INC NASDAQ 3,655.622 - - 5.1428 -
Local Peer PRINCIPIA BIOPHARMA INC NASDAQ 3,322.510 - - 9.4540 -
Local Peer REATA PHARMACEUTICALS INC NASDAQ 3,154.332 - - 13.6181 -
Other Local Peers NEKTAR THERAPEUTICS (NASDAQ), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), APELLIS PHARMACEUTICALS INC (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), OPKO HEALTH INC (NASDAQ), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), KARUNA THERAPEUTICS INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), AKCEA THERAPEUTICS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), GENERATION BIO CO (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), ATHENEX INC (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), QUANTERIX CORPORATION (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), CONSTELLATION PHARMACEUTICALS INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), PETIQ INC (NASDAQ), ANNEXON INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), PROVENTION BIO INC (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), INOZYME PHARMA INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), 89BIO INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), TRICIDA INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), BEYONDSPRING INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), IMARA INC (NASDAQ), BIOSPECIFICS TECHNOLOGIES CORP (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), DURECT CORP (NASDAQ), AC IMMUNE SA (NASDAQ), IMMUNIC INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), AMAG PHARMACEUTICS INC (NASDAQ), UROVANT SCIENCES LTD (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), VYNE THERAPEUTICS INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), POLYPID LTD (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), LIQUIDIA TECHNOLOGIES INC (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), VERU INC (NASDAQ), MUSTANG BIO INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), HARROW HEALTH INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), OBSEVA SA (NASDAQ), GENPREX INC (NASDAQ), EVOLUS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), LANTERN PHARMA INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), GRITSTONE ONCOLOGY INC (NASDAQ), MEDIWOUND LTD (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), EYENOVIA INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), KITOV PHARMA LTD SPON ADS EACH REP 10 ORD SHS (R/S) (NASDAQ), NOVAN INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), BAUDAX BIO INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), PAINREFORM LTD (NASDAQ), PROPHASE LABS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), MANNATECH INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), MILLENDO THERAPEUTICS INC (NASDAQ), SUN BIOPHARMA INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), SPRING BANK PHARMACEUTICALS INC (NASDAQ), NOVUS THERAPEUTICS INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ), TELIGENT INC NEW (NASDAQ)
Global Peer JOHNSON & JOHNSON NYSE 383,496.561 25.365 25.255 6.0894 2.574
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 214,905.597 30.491 29.773 3.9937 2.115
Global Peer MERCK & CO INC NYSE 209,749.873 21.310 20.016 7.5881 2.736
Global Peer PFIZER INC NYSE 200,325.524 12.311 14.137 3.1137 4.033
Global Peer ABBVIE INC NYSE 152,181.291 19.406 22.049 10.3469 4.266
Global Peer ELI LILLY AND COMPANY NYSE 143,719.182 30.988 25.581 35.1140 1.719
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 134,086.296 38.990 - 2.7312 2.792
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 125,175.394 21.437 20.408 13.8319 1.647
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 94,828.104 16.003 14.832 5.6460 5.160
Global Peer TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS NYSE 58,421.013 143.577 59.119 1.3448 -
Other Global Peers WUXI APPTEC (HKEx), HANSOH PHARMA (HKEx), INNOVENT BIO (HKEx), CANSINOBIO-B (HKEx), SINOPHARM (HKEx), JUNSHI BIO (HKEx), SH PHARMA (HKEx), BAIYUNSHAN PH (HKEx), HYGEIA HEALTH (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), HENLIUS-B (HKEx), CHINAGRANDPHARM (HKEx), CHINARES PHARMA (HKEx), CMS (HKEx), HEPALINK (HKEx), AKESO-B (HKEx), ADC THERAPEUTICS SA (NYSE), TRAD CHI MED (HKEx), ZYMEWORKS INC (NYSE), UNITED LAB (HKEx), OCUMENSION-B (HKEx), SSY GROUP (HKEx), INNOCARE-B (HKEx), AMNEAL PHARMACEUTICALS INC (NYSE), Kimia Farma Tbk. (IDX), CSTONE PHARMA-B (HKEx), CKLIFE SCIENCES (HKEx), Soho Global Health Tbk. (IDX), TONGRENTANGCM (HKEx), IMMUNOTECH-B (HKEx), HUA MEDICINE-B (HKEx), IGBB (Bursa), SHINEWAY PHARM (HKEx), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), STARPHARMA HOLDINGS LIMITED (ASX), FUSEN PHARM (HKEx), AFT PHARMACEUTICALS LTD (ASX), PYC THERAPEUTICS LIMITED (ASX), BSTEAD (Bursa), TOT BIOPHARM-B (HKEx), PHARMA (Bursa), LANNETT CO INC (NYSE), DAWNRAYS PHARMA (HKEx), ZHONGZHIPHARM (HKEx), CH BIOTECH SER (HKEx), BIOMX INC (NYSE American), RECCE PHARMACEUTICALS LTD (ASX), IX Biopharma (SGX), KOTRA (Bursa), Merck Tbk. (IDX), Hyphens Pharma (SGX), NEW RAY MEDIC (HKEx), Phapros Tbk. (IDX), IP (SET), ONCOSIL MEDICAL LIMITED (ASX), NEP INTERLONG (HKEx), PAK FAH YEOW (HKEx), RACE ONCOLOGY LTD (ASX), NOVA (Bursa), PALLA PHARMA LTD (ASX), CHARMACY PHAR (HKEx), BIOHLDG (Bursa), NOXOPHARM LTD (ASX), NC HEALTHCARE (HKEx), WAI YUEN TONG (HKEx), IMMURON LIMITED (ASX), TBG DIAGNOSTICS LTD (ASX), INVION LTD (ASX), SANAI HEALTH GP (HKEx), PURAPHARM (HKEx), EXTRAWELL PHAR (HKEx), MEDLAB CLINICAL LIMITED (ASX), JCT (SET), AGEX THERAPEUTICS INC (NYSE American), ANNOVIS BIO INC (NYSE American), EXOPHARM LTD (ASX), PHARMAXIS (ASX), SUNZEN (Bursa), ACRUX (ASX), FIJI KAVA LTD (ASX), SINOLIFE UTD (HKEx), PASHUN INT'L (HKEx), TALI DIGITAL LIMITED (ASX), TIMBER PHARMACEUTICALS INC (NYSE American), CRESO PHARMA LTD (ASX), SUDA PHARMACEUTICALS LTD (ASX), CELLMID LIMITED (ASX), Merck Sharp Dohme Pharma Tbk. (IDX), FARMAFORCE LTD (ASX), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.900
-6.53 %
10 Days --0.720
-5.29 %
20 Days --0.580
-4.31 %
Medium Term Return 3 Months -+0.440
+3.53 %
6 Months -+5.610
+77.06 %
1 Year -+1.030
+8.68 %
Long Term Return 2 Years --9.220
-41.70 %
3 Years -+6.160
+91.53 %
Annualised Return Annualised --
+24.19 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 5.605 - 18.960 Change From 1 Year Low +7.285 % Change From 1 Year Low (%) +129.97
Change From 1 Year High -6.070 % Change From 1 Year High (%) -32.01
2 Years Range 5.605 - 34.920 Change From 2 Years Low +7.285 % Change From 2 Years Low (%) +129.97
Change From 2 Years High -22.030 % Change From 2 Years High (%) -63.09
5 Years Range 5.480 - 34.920 Change From 5 Years Low +7.410 % Change From 5 Years Low (%) +135.22
Change From 5 Years High -22.030 % Change From 5 Years High (%) -63.09
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: hereditary angioedema (HAE) and diabetic macular edema (DME). The company was founded by T. Andrew Crockett, Edward P. Feener, and Lloyd Paul Aiello and is headquartered in Cambridge, MA.

Historical Price Data

Date Open High Low Close Volume VWAP
25 Sep 2020 12.740 12.940 12.570 12.890 31,582 -
24 Sep 2020 13.460 13.460 12.440 12.750 43,150 -
23 Sep 2020 13.400 13.670 13.120 13.450 58,632 -
22 Sep 2020 13.790 13.790 12.680 13.470 47,453 -
21 Sep 2020 13.600 13.900 12.560 13.280 120,162 -
18 Sep 2020 13.600 13.900 13.350 13.790 62,911 -
17 Sep 2020 13.350 13.660 12.540 13.390 22,215 -
16 Sep 2020 13.900 14.150 13.360 13.400 40,400 -
15 Sep 2020 13.920 14.190 13.780 13.880 49,347 -
14 Sep 2020 13.540 14.070 13.340 13.990 44,904 -
11 Sep 2020 14.050 14.460 12.650 13.610 25,214 -
10 Sep 2020 13.615 14.340 13.590 13.840 39,251 -
09 Sep 2020 13.300 13.990 12.820 13.460 23,672 -
08 Sep 2020 13.050 13.320 12.510 13.030 31,193 -
04 Sep 2020 12.530 13.980 12.400 13.050 101,942 -
03 Sep 2020 12.700 12.700 12.100 12.310 59,306 -
02 Sep 2020 12.580 12.900 12.100 12.730 37,456 -
01 Sep 2020 12.970 13.030 12.490 12.640 25,631 -
31 Aug 2020 13.380 13.440 12.900 13.100 68,142 -
28 Aug 2020 12.990 13.490 12.650 13.470 28,786 -
27 Aug 2020 12.930 12.930 11.640 12.770 31,925 -
26 Aug 2020 12.980 12.990 12.520 12.740 35,877 -
Summary
Current 2 Weeks
(14 Sep 2020 to 25 Sep 2020)
13.540 14.190 12.440 12.890 520,756 -
Previous 2 Weeks
(28 Aug 2020 to 11 Sep 2020)
12.990 14.190 12.440 13.610 440,593 -
4 Weeks from
(31 Jul 2020 to 27 Aug 2020)
10.100 14.190 9.620 12.770 1,449,916 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.